HeartBeam this week announced it appointed Lance Myers to chief artificial intelligence scientist. Myers will be responsible for driving HeartBeam’s digital health data analytics and body-worn biosensor technology company’s AI strategy and how it is applied to its core technology. “We’ve made tremendous progress with our deep learning approach with data demonstrating that combining HeartBeam […]
HeartBeam
HeartBeam has a new CFO
HeartBeam this week announced it appointed Timothy Cruickshank as chief financial officer. Cruickshank has more than 15 years of public company experience. He succeeds CFO Richard Brounstein, who retired in February. Prior to joining the company, Cruickshank was CFO of ImpediMed since 2019. “Tim has an outstanding record of delivering results and creating value and […]
The latest AI-powered cardiology devices you need to know
Artificial intelligence is increasingly becoming integral in advancing medtech, including devices to treat heart disease. Think AI-powered cardiology. AI-driven technologies could improve diagnostic capabilities, patient outcomes and clinical workflows. These technologies leverage machine learning algorithms and vast datasets to provide more accurate diagnoses and patient care. In cardiology, AI-powered devices are changing how heart conditions […]
HeartBeam AI with VCG outperforms cardiologists in detecting arrhythmias
HeartBeam (Nasdaq:BEAT) today announced new data highlighting the potential of its AI combined with vectorcardiography (VCG). Study results showed that HeartBeam AI with VCG outperformed an expert panel of heart rhythm cardiologists in detecting atrial flutter. HeartBeam’s AI algorithm uses deep learning to detect abnormalities in the timing or pattern of heartbeats. VCG measures the […]
The top stories out of Heart Rhythm Society 2024
Once again, the top players in cardiac care gathered en masse as Heart Rhythm Society (HRS) 2024 took place in Boston last week. From implantable rhythm management devices to AI-powered monitoring and diagnostic technology, Heart Rhythm 2024 had it all. Once again, pulsed field ablation (PFA) took center stage as companies continue to build on […]
HeartBeam unveils AI program for cardiac insights
HeartBeam (Nasdaq:BEAT) announced today that it made significant developments in the AI applied to its proprietary ECG technology. Santa Clara, California-based HeartBeam develops its proprietary vectorelectrocardiography (VECG) technology. The company aims to provide diagnostic and prognostic insights about cardiac health beyond what standard 12-lead ECGs provide. HeartBeam’s VECG technology collects 3D signals of the heart […]
HeartBeam names Deborah Castillo VP of regulatory affairs
HeartBeam (Nasdaq:BEAT) announced today that it appointed Deborah Castillo as its VP of regulatory affairs. Castillo, an experienced biomedical engineer, brings with her knowledge of the FDA, EU and Health Canada regulations, HeartBeam says. Her experience spans cardiovascular diseases, neuroscience and medical devices that support these functions. Before joining HeartBeam, Castillo served as director of […]
HeartBeam adds duo of medtech veterans to its board
HeartBeam (Nasdaq:BEAT) announced today that it appointed Ken Nelson and Mark Strome to its board of directors. The appointment of Nelson and Strome became effective on June 5, 2023. HeartBeam develops a proprietary 3D-vector ECG platform intended for patient use at home. Nelson, 48, brings with him 20 years of experience in digital health, medical […]
HeartBeam partners with Samsung to boost at-home cardiac care
HeartBeam has announced a strategic alliance agreement (SAA) with global tech giant Samsung. The alliance, announced today, builds upon an existing SAA between Samsung and Livmor, whose assets HeartBeam acquired earlier this year. Livmor created the FDA-cleared wearable Halo atrial fibrillation detection system — an FDA-cleared, Samsung-Galaxy-watch-based arrhythmia detection tool. Meanwhile, HeartBeam recently secured a […]
HeartBeam wins AI-related patent for handheld vector ECG
HeartBeam (Nasaq:BEAT) announced today that it received a key patent relating to AI capabilities for its AIMIGo system. The U.S. Patent and Trademark Office (USPTO) issued the allowance for a patent titled “Hand Held Device for Automatic Cardiac Risk and Diagnostic Assessment.” The patent describes a system that combines recorded cardiac signals from AIMIGo with […]
HeartBeam submits AIMIGo vector ECG for FDA 510(k) clearance
HeartBeam (Nasdaq:BEAT) announced today that it submitted a 510(k) application to the FDA for its AIMIGo system. AIMIGo, a personal, portable vector electrocardiogram (VECG) system assists patients and clinicians in assessing cardiac symptoms. It utilizes a reusable, credit card-sized VECG recording device and cloud-based software. The system can deliver critical data to clinicians in real-time outside […]
